Fondocept is formed by Steffen Ernst, PhD based on >25 years’ experience in biotech innovation at Novozymes and M.I.T. with shorter stints at Radiometer Medical, Dow Chemical, and Merck & Co.
Steffen Ernst has delivered significant innovation and business development advances across multiple functional disciplines and application fields:
- Commercialization in new business area – including P&L responsibility
- Early business development to initiate new areas of business.
- Innovation process management across Novozymes’ global organization.
- Partnership management for strategic collaborations
- Application research in food, animal feed, and agro-processing areas.
- Robotic high-throughput screening and directed evolution
- Fermentation-based production and production cost optimization.
- Project and portfolio management
- Strategy and execution for IP-portfolios and partnership agreement complexes.
Application fields include:
- Animal health & nutrition
- Food and nutrition – including innovation-based partnerships with multiple top-10 global food producers.
- Agroprocessing including biorefineries for commodity crops.
- Biobased chemicals and bioenergy
- Household care
- Personal care
- Biopharmaceutical technology
Fondocept manages to go both deep and wide on issues that involve technology, commercialization, partnering, IP, agreements, regulatory, supply, organization, and/or financing.